GGrantIndex
← Leaderboards

Carole L Marcus

Johns Hopkins University

Google Scholar ↗PubMed ↗ORCID ↗
$11,334,904
Attributed
$11,334,904
Total exposure
22
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.1M · FY2005–16
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$11,334,904 · 22

By mechanism

R01$7,287,247 · 3
U01$3,061,347 · 1
R56$500,000 · 1
R21$383,938 · 1
M01$102,372 · 16

Top collaborators

No co-investigators on record.

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Human Subject”

Research focus

Human SubjectSleep ApneaClinical ResearchPolysomnographySleepRespiratory Disorder DiagnosisObesityChild (0-11)ChildhoodObstructive Sleep ApneaApneaIndexingPrevalenceMiddle Childhood (6-11)PhenotypeArousalMorbidity - Disease RateResponseRandomizedFallsRespiratory Airway VolumeCohortNeurobehavioralNeuraxis

Grant awards (58)

IMPACT OF TREATMENT OF MILD SLEEP-DISORDERED BREATHING ON CHILDREN'S HEALTH-CCC$1,528,384
U01 · FY2016 · HL · contact PI
Utility of nasal steroids for treatment of childhood obstructive sleep apnea$613,038
R01 · FY2016 · HL · contact PI
IMPACT OF TREATMENT OF MILD SLEEP-DISORDERED BREATHING ON CHILDREN'S HEALTH-CCC$1,532,963
U01 · FY2015 · HL · contact PI
Utility of nasal steroids for treatment of childhood obstructive sleep apnea$609,175
R01 · FY2015 · HL · contact PI
Utility of nasal steroids for treatment of childhood obstructive sleep apnea$651,368
R01 · FY2014 · HL · contact PI
Pathophysiology of Childhood Obstructive Sleep Apnea$574,629
R01 · FY2012 · HL · contact PI
Long-term effects of caffeine therapy for apnea of prematurity on sleep disorders$71,946
R01 · FY2012 · HL · contact PI
Pathophysiology of Childhood Obstructive Sleep Apnea$577,609
R01 · FY2011 · HL · contact PI
Long-term effects of therapeutic caffeine use for apnea of prematurity on sleep d$282,648
R01 · FY2011 · HL · contact PI
Pathophysiology of Childhood Obstructive Sleep Apnea$583,443
R01 · FY2010 · HL · contact PI
Long-term effects of therapeutic caffeine use for apnea of prematurity on sleep d$354,714
R01 · FY2010 · HL · contact PI
Pathophysiology of Childhood Obstructive Sleep Apnea$592,118
R01 · FY2009 · HL · contact PI
Long-term effects of therapeutic caffeine use for apnea of prematurity on sleep d$417,311
R01 · FY2009 · HL · contact PI
Pathophysiology of Childhood Obstructive Sleep Apnea$500,000
R56 · FY2008 · HL · contact PI
Pathophysiology of Childhood Obstructive Sleep Apnea$313,460
R01 · FY2006 · HL · contact PI
Pathophysiology of Childhood Obstructive Sleep Apnea$321,325
R01 · FY2005 · HL
PATHOPHYSIOLOGY OF CHILDHOOD OBSTRUCTIVE SLEEP APNEA SYNDROME$81,084
M01 · FY2005 · RR
NONINVASICE VENTILATION IN PATIENTS WITH CYSTIC FIBROSIS$9,031
M01 · FY2005 · RR
RESPIRATORY-RELATED EVOKED POTENTIALS IN CHILDREN WITH OSAS$4,735
M01 · FY2005 · RR
Pathophysiology of Childhood Obstructive Sleep Apnea$323,185
R01 · FY2004 · HL
Noninvasive Ventilation in Children with Cystic Fibrosis$182,786
R21 · FY2004 · HD
Obstructive Sleep Apnea in Adults with Down Syndrome$3,134
M01 · FY2004 · RR
Respiratory-related evoked potentials in children with OSAS$2,977
M01 · FY2004 · RR
Evaluation of the relationship between upper airway collapsibility and body size$940
M01 · FY2004 · RR
Passive Motion Ventilation in Children with CCHS$314
M01 · FY2004 · RR
Upper Airway Collapsibility during Rem sleep$157
M01 · FY2004 · RR
Pathophysiology of Childhood Obstructive Sleep Apnea$337,624
R01 · FY2003 · HL
Noninvasive Ventilation in Children with Cystic Fibrosis$201,152
R21 · FY2003 · HD
Pathophysiology of Childhood Obstructive Sleep Apnea$327,000
R01 · FY2002 · HL
MRI STRUCTURAL EVALUATION OF CHILDREN WITH OBSTRUCTIVE SLEEP APNEA$0
M01 · FY2002 · RR
NONINVASIVE MEASURE OF FLOW LIMITS IN CHILDREN WITH OSAS$0
M01 · FY2002 · RR
TOPICAL ANESTHESIA EFFECTS ON UPPER AIRWAY COLLAPSE$0
M01 · FY2002 · RR
SLEEP DISORDERED BREATHING IN CHILDREN WITH MARFRAN SYN$0
M01 · FY2002 · RR
DEVELOPMENTAL DETERMINANTS OF UPPER AIRWAY COLLAPSE$0
M01 · FY2002 · RR
AROUSAL THRESHOLD TO AUDITORY STIMULUS IN SLEEP APNEA$0
M01 · FY2002 · RR
MRI STRUCTURAL EVALUATION OF CHILDREN WITH OSAS$0
M01 · FY2002 · RR
DEVELOPMENTAL DETERMINANTS OF UPPER AIRWAY COLLAPSIBILITY$0
M01 · FY2002 · RR
AROUSAL THRESHOLD TO AUDITORY STIMULATION DURING SLEEP IN CHILDREN$0
M01 · FY2002 · RR
PATHOPHYSIOLOGY OF CHILDHOOD OBSTRUCTIVE SLEEP APNEA$170,379
R01 · FY2001 · HL
MRI STRUCTURAL EVALUATION OF CHILDREN WITH OBSTRUCTIVE SLEEP APNEA$0
M01 · FY2001 · RR
NONINVASIVE MEASURE OF FLOW LIMITS IN CHILDREN WITH OSAS$0
M01 · FY2001 · RR
TOPICAL ANESTHESIA EFFECTS ON UPPER AIRWAY COLLAPSE$0
M01 · FY2001 · RR
SLEEP DISORDERED BREATHING IN CHILDREN WITH MARFRAN SYN$0
M01 · FY2001 · RR
DEVELOPMENTAL DETERMINANTS OF UPPER AIRWAY COLLAPSE$0
M01 · FY2001 · RR
AROUSAL THRESHOLD TO AUDITORY STIMULUS IN SLEEP APNEA$0
M01 · FY2001 · RR
MRI STRUCTURAL EVALUATION OF CHILDREN WITH OSAS$0
M01 · FY2001 · RR
DEVELOPMENTAL DETERMINANTS OF UPPER AIRWAY COLLAPSIBILITY$0
M01 · FY2001 · RR
AROUSAL THRESHOLD TO AUDITORY STIMULATION DURING SLEEP IN CHILDREN$0
M01 · FY2001 · RR
PATHOPHYSIOLOGY OF CHILDHOOD OBSTRUCTIVE SLEEP APNEA$166,275
R01 · FY2000 · HL
SLEEP DISORDERED BREATHING IN CHILDREN WITH MARFRAN SYN$0
M01 · FY2000 · RR
AROUSAL THRESHOLD TO AUDITORY STIMULUS IN SLEEP APNEA$0
M01 · FY2000 · RR
MRI STRUCTURAL EVALUATION OF CHILDREN WITH OSAS$0
M01 · FY2000 · RR
DEVELOPMENTAL DETERMINANTS OF UPPER AIRWAY COLLAPSIBILITY$0
M01 · FY2000 · RR
AROUSAL THRESHOLD TO AUDITORY STIMULATION DURING SLEEP IN CHILDREN$0
M01 · FY2000 · RR
MRI STRUCTURAL EVALUATION OF CHILDREN WITH OBSTRUCTIVE SLEEP APNEA$0
M01 · FY2000 · RR
NONINVASIVE MEASURE OF FLOW LIMITS IN CHILDREN WITH OSAS$0
M01 · FY2000 · RR
TOPICAL ANESTHESIA EFFECTS ON UPPER AIRWAY COLLAPSE$0
M01 · FY2000 · RR
DEVELOPMENTAL DETERMINANTS OF UPPER AIRWAY COLLAPSE$0
M01 · FY2000 · RR